Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-15 | Dr. Mark R. MunchCorporate Exec. VP and President of Bruker Nano Group & Corporate | -2,00k | 43,42k | Derivative Exercise and Sale | 22,19 - 43,90 | 84,15k | - |
| 2026-04-15 | Dr. Mark R. MunchCorporate Exec. VP and President of Bruker Nano Group & Corporate | -2,00k | 35,42k | Derivative Exercise and Sale | 22,19 - 39,90 | 84,15k | - |
| 2026-03-13 | Dr. Mark R. MunchCorporate Exec. VP and President of Bruker Nano Group & Corporate | -2,00k | 26,50k | Derivative Exercise and Sale | 22,19 - 35,44 | 84,15k | - |
| 2026-02-13 | Dr. Mark R. MunchCorporate Exec. VP and President of Bruker Nano Group & Corporate | -2,00k | 29,50k | Derivative Exercise and Sale | 22,19 - 36,94 | 84,15k | - |
| 2026-02-15 | Mr. Thomas M. BuresCAO | -274,00 | 10,00k | Sale to Issuer | 36,51 | 969,00 | -22,04% |
| 2026-01-15 | Dr. Mark R. MunchCorporate Exec. VP and President of Bruker Nano Group & Corporate | -2,00k | 54,02k | Derivative Exercise and Sale | 22,19 - 49,20 | 84,15k | - |
| 2026-01-12 | Dr. Mark R. MunchCorporate Exec. VP and President of Bruker Nano Group & Corporate | -7,00k | 229,67k | Derivative Exercise and Sale | 22,19 - 55,00 | 84,15k | - |
| 2026-01-05 | Dr. Mark R. MunchCorporate Exec. VP and President of Bruker Nano Group & Corporate | -33,84k | 929,67k | Derivative Exercise and Sale | 22,19 - 50,00 | 84,15k | - |
| 2025-12-01 | Mr. Richard A. PackerLead Director | 4,97k | 119,33k | Derivative Exercise and Retained Stock | 24,00 | 85,88k | 6,15% |
| 2025-12-01 | Mr. Richard A. PackerLead Director | -5,03k | 122,56k | Derivative Exercise and Sale | 24,00 - 48,38 | 85,88k | - |
| 2025-11-06 | Mr. John A. OrnellIndependent Director | 3,77k | 90,41k | Derivative Exercise and Retained Stock | 24,00 | 31,91k | 13,38% |
| 2025-11-06 | Mr. John A. OrnellIndependent Director | -6,23k | 93,50k | Derivative Exercise and Sale | 24,00 - 39,00 | 31,91k | - |
| 2025-09-12 | Dr. Cynthia M. FriendInitié | 765,00 | 20,02k | Derivative Exercise and Retained Stock | 26,17 | 14,72k | 5,48% |
| 2025-09-12 | Dr. Cynthia M. FriendInitié | -3,54k | 21,48k | Derivative Exercise and Sale | 26,17 - 32,25 | 14,72k | - |
| 2025-08-09 | Dr. Mark R. MunchCorporate Exec. VP and President of Bruker Nano Group & Corporate | -3,73k | 113,83k | Sale to Issuer | 30,43 - 30,78 | 84,15k | -4,24% |
| 2025-08-09 | Mr. Gerald N. HermanExec. VP & CFO | -4,65k | 141,87k | Sale to Issuer | 30,43 - 30,78 | 56,20k | -7,64% |
| 2025-08-09 | Dr. Frank H. LaukienChairman, CEO & President | -12,92k | 394,76k | Sale to Issuer | 30,43 - 30,78 | 40,40M | -0,03% |
| 2025-08-05 | Dr. Mark R. MunchCorporate Exec. VP and President of Bruker Nano Group & Corporate | -844,00 | 27,07k | Sale to Issuer | 32,07 | 77,82k | -1,07% |
| 2025-08-05 | Dr. Frank H. LaukienChairman, CEO & President | -3,58k | 114,87k | Sale to Issuer | 32,07 | 40,38M | -0,01% |
| 2025-08-05 | Mr. Gerald N. HermanExec. VP & CFO | -577,00 | 18,50k | Sale to Issuer | 32,07 | 50,89k | -1,12% |
| 2025-06-06 | Dr. Frank H. LaukienChairman, CEO & President | 2,61k | 100,04k | Achat | 38,36 | 40,37M | 0,01% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
